Literature DB >> 30246588

Utilization of Screening Mammograms in the Medicare Population Before and After the Affordable Care Act Implementation.

Laura M Bozzi1, Bruce Stuart1, Eberechukwu Onukwugha1, Sarah E Tom2.   

Abstract

Objective: This study examined screening mammograms in women aged 65 to 74 years and 75+ years before and after the Affordable Care Act (ACA) implementation. Method: This repeated cross-sectional study of community-dwelling women age 65+ years without a history of breast cancer or mastectomy utilized the Medicare Current Beneficiary Survey and Medicare fee-for-service claims data from 2001 to 2013. We used covariate-adjusted logistic regression with generalized estimating equations, stratified by age group.
Results: The adjusted odds of screening mammograms in women aged 65-74 (n = 742) and 75+ years (n = 681) were lower in 2013 (odds ratio [OR]: 0.75, 95% confidence interval [CI]: [0.67, 0.83]; OR: 0.67, 95% CI: [0.60, 0.75], respectively) than the odds of screening mammograms in 2001. Discussion: Annual screening mammograms decreased in women aged 65 to 74 years and 75+ years, despite increased access from the ACA implementation. Future research as to why women are no longer receiving screening mammograms, such as changes in physician specialty guidelines, is warranted.

Entities:  

Keywords:  Medicare; Patient Protection and Affordable Care Act; screening mammograms; women’s health

Mesh:

Year:  2018        PMID: 30246588      PMCID: PMC7891892          DOI: 10.1177/0898264318802047

Source DB:  PubMed          Journal:  J Aging Health        ISSN: 0898-2643


  21 in total

1.  Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.

Authors:  T M Shaneyfelt; M F Mayo-Smith; J Rothwangl
Journal:  JAMA       Date:  1999-05-26       Impact factor: 56.272

2.  Screening for breast cancer: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

3.  Trends in Breast Cancer Screening: Impact of U.S. Preventive Services Task Force Recommendations.

Authors:  Soudabeh Fazeli Dehkordy; Kelli S Hall; Allison L Roach; Edward D Rothman; Vanessa K Dalton; Ruth C Carlos
Journal:  Am J Prev Med       Date:  2015-04-01       Impact factor: 5.043

4.  The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women?

Authors:  Ramzi G Salloum; Gail A Jensen; Andrea K Biddle
Journal:  J Womens Health (Larchmt)       Date:  2012-11-12       Impact factor: 2.681

5.  Physician adherence to U.S. Preventive Services Task Force mammography guidelines.

Authors:  Jennifer Corbelli; Sonya Borrero; Rachel Bonnema; Megan McNamara; Kevin Kraemer; Doris Rubio; Irina Karpov; Melissa McNeil
Journal:  Womens Health Issues       Date:  2014 May-Jun

6.  Cost-related medication nonadherence in older patients with rheumatoid arthritis.

Authors:  Leslie R Harrold; Becky A Briesacher; Dan Peterson; Ashley Beard; Jeanne Madden; Fang Zhang; Jerry H Gurwitz; Stephen B Soumerai
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

7.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

Review 8.  A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Authors:  Lydia E Pace; Nancy L Keating
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

9.  Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.

Authors:  Hajar Kadivar; Barbara A Goff; William R Phillips; C Holly A Andrilla; Alfred O Berg; Laura-Mae Baldwin
Journal:  J Gen Intern Med       Date:  2013-08-14       Impact factor: 5.128

10.  Mammography Screening in a Large Health System Following the U.S. Preventive Services Task Force Recommendations and the Affordable Care Act.

Authors:  Heidi D Nelson; Roshanthi Weerasinghe; Lian Wang; Gary Grunkemeier
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.